You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

leflunomide

Showing 1 - 25 of 172
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Idiopathic Pulmonary Hemosiderosis, Leflunomide Trial in Guangzhou (Leflunomide, Steroid Drug)

Recruiting
  • Idiopathic Pulmonary Hemosiderosis
  • Leflunomide
  • Leflunomide
  • Steroid Drug
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Jun 30, 2023

Henoch-Schonlein Purpura Trial in Guangzhou (Leflunomide)

Recruiting
  • Henoch-Schonlein Purpura
  • Leflunomide
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jul 1, 2023

MEN1 Gene Mutation Trial in Basel (Leflunomide 20 mg)

Not yet recruiting
  • MEN1 Gene Mutation
  • Leflunomide 20 mg
  • Basel, Switzerland
    Unispital Basel
Nov 1, 2022

Autoimmune Diseases Trial in Beijing (Diprospan plus iguratimod, Diprospan plus leflunomide, Prednisone plus leflunomide)

Recruiting
  • Autoimmune Diseases
  • Diprospan plus iguratimod
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Mar 16, 2023

Rheumatoid Arthritis, Insufficient Response to Methotrexate or Leflunomide Trial in Strasbourg (Methotrexate + targeted therapy

Recruiting
  • Rheumatoid Arthritis
  • Insufficient Response to Methotrexate or Leflunomide
  • Methotrexate + targeted therapy administration
  • methotrexate or leflunomide + sulfasalazine + hydroxychloroquine administration
  • Strasbourg, France
    Hôpitaux Universitaires de Strasbourg
Jul 8, 2022

Autoimmune Diseases Trial in Beijing (Prednisone and Mycophenolate Mofetil, Mycophenolate Mofetil, Leflunomide)

Recruiting
  • Autoimmune Diseases
  • Prednisone and Mycophenolate Mofetil
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Mar 16, 2023

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Best Practice
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Duarte (Cholestyramine, Leflunomide, Steroid Therapy)

Recruiting
  • Acute Graft Versus Host Disease
  • Hematopoietic and Lymphoid System Neoplasm
  • Duarte, California
    City of Hope Medical Center
Jan 5, 2023

PTEN-null Advanced Solid Tumors Trial in New York (Leflunomide)

Not yet recruiting
  • PTEN-null Advanced Solid Tumors
  • Leflunomide
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jul 8, 2022

Chronic GVHD, Steroid Refractory GVHD Trial in Duarte (Leflunomide)

Recruiting
  • Chronic Graft Versus Host Disease
  • Steroid Refractory Graft Versus Host Disease
  • Leflunomide
  • Duarte, California
    City of Hope Medical Center
Sep 14, 2022

Recurrent Lymphoproliferative Disorder, Refractory Lymphoproliferative Disorder Trial in Duarte (Leflunomide)

Active, not recruiting
  • Recurrent Lymphoproliferative Disorder
  • Refractory Lymphoproliferative Disorder
  • Leflunomide
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022

Myasthenia Gravis Trial in GuangZhou (Azathioprine, Leflunomide)

Completed
  • Myasthenia Gravis
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital, SUN YAT-SEN UNIVERSITY
Apr 6, 2022

Takayasu Arteritis Trial in China (Leflunomide 10mg Tab, Prednisone Acetate, Placebos)

Recruiting
  • Takayasu Arteritis
  • Leflunomide 10mg Tab
  • +2 more
  • Beijing, Beijing, China
  • +6 more
Jun 25, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Duarte (Laboratory Biomarker Analysis, Leflunomide,

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Oct 4, 2021

Primary Sjögren's Syndrome (pSS) Trial in Le Kremlin-Bicêtre (Hydroxychloroquine 400mg/d, Leflunomide 20mg/d, Mycophenolate

Recruiting
  • Primary Sjögren's Syndrome (pSS)
  • Hydroxychloroquine 400mg/d
  • +5 more
  • Le Kremlin-Bicêtre, France
    Raphaele Seror
May 2, 2022

Musculoskeletal Disease Other, GVHD, Chronic Trial in Navi Mumbai (Leflunomide tablet)

Recruiting
  • Musculoskeletal Disease Other
  • GVHD, Chronic
  • Leflunomide tablet
  • Navi Mumbai, Maharashtra, India
    Tata Memorial Centre, Advanced Centre for Treatment, Research an
Jun 18, 2021

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Duarte (Dexamethasone, Leflunomide, Pomalidomide)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Duarte, California
    City of Hope Medical Center
Jan 10, 2022

COVID-19 Trial in Chertsey (leflunomide)

Active, not recruiting
  • COVID-19
  • leflunomide
  • Chertsey, United Kingdom
    Ashford and St Peters Hospital NHS Foundation Trust
Aug 12, 2021

Arthritis, Rheumatoid Trial in Jinan (Iguratimod, Methotrexate, Adalimumab Injection)

Recruiting
  • Arthritis, Rheumatoid
  • Jinan, Shandong, China
    Qilu Hospital
Nov 28, 2022

ANCA Associated Vasculitis, Maintenance Therapy Trial in China (Leflunomide, Azathioprine Tablets)

Recruiting
  • ANCA Associated Vasculitis
  • Maintenance Therapy
  • Leflunomide
  • Azathioprine Tablets
  • Hefei, Anhui, China
  • +3 more
Nov 26, 2021

Rheumatoid Arthritis Trial in Omaha (Leflunomide, Methotrexate-Sulfasalazine-Hydroxychloroquine,

Completed
Has Results
  • Rheumatoid Arthritis
  • Leflunomide
  • +2 more
  • Omaha, Nebraska
    University of Nebraska Medical Center
Jan 14, 2021

Rheumatoid Arthritis Trial in Pondicherry (Methotrexate, Leflunomide, Hydroxychloroquine)

Terminated
Has Results
  • Rheumatoid Arthritis
  • Pondicherry, India
    Department of Clinical Immunology , Jawaharlal Institute of Post
Jul 25, 2021

Psoriatic Arthritis, Withdrawal, Reduction Trial in Erlangen (Prednisolone, Sulfasalazine, Leflunomide)

Recruiting
  • Psoriatic Arthritis
  • +2 more
  • Erlangen, Bavaria, Germany
    Universitätsklinikum Erlangen
Nov 10, 2022

COVID-19 Trial in Chicago (Leflunomide)

Unknown status
  • COVID-19
  • Leflunomide
  • Chicago, Illinois
    University of Chicago
Oct 27, 2020

Psoriatic Arthritis Trial in Oxford (Methotrexate, Sulfasalazine, Leflunomide)

Completed
Has Results
  • Psoriatic Arthritis
  • Oxford, Oxfordshire, United Kingdom
    Oxford University Hospitals NHS Trust
May 7, 2021